ArticleThe breast journal2022

Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study.

Jin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.